520 Patients, 31 New Diagnoses and One Denominator Problem: Calculating Diabetes Prevalence, Cumulative Incidence and Incidence Rate for a Rural Clinic and Comparing Them With National Trends
[Student Name]
University of Phoenix
DNP/701: Biostatistics and Epidemiology
Week 1 Assignment
[Instructor Name]
[Date]
The clinic and its figures are a composite written for a model paper.
I am a DNP student and a nurse practitioner at a rural health clinic network in south Georgia that serves 4,000 adults. Our medical director asked me a simple question: "How much diabetes do we have, and is it growing?" Answering it requires two different measures, prevalence and incidence, and careful attention to who is counted. This paper defines those measures, calculates them for our panel and compares the results with national data.
Defining the Measures
Noordzij et al. (2010) define prevalence as the proportion of a population with a disease at a given time, reflecting both how often disease arises and how long it lasts, and incidence as the occurrence of new cases in a population at risk over a specified period. They distinguish cumulative incidence, the proportion of an at-risk population that develops the disease over a period, from the incidence rate, which divides new cases by the total person-time at risk. Prevalence is useful for planning services; incidence is useful for studying causes and the effect of prevention.
Prevalence in Our Clinic
On January 1, 520 of our 4,000 adult patients had a diagnosis of diabetes in the health record. Point prevalence is 520 divided by 4,000, or 13.0%. This tells our director how many patients need diabetes services today: annual eye and foot examinations, A1c testing and education.
Cumulative Incidence
To measure new diabetes, the denominator must exclude patients who already have it. The population at risk on January 1 was 4,000 minus 520, or 3,480 adults. During the year, 31 of these patients received a new diabetes diagnosis. Cumulative incidence is 31 divided by 3,480, which works out to 8.9 new cases for every 1,000 adults who began the year free of diabetes.
The same 31 new cases give a rate of 7.8 or 8.9 per 1,000 depending on whether the denominator counts people who could never become a new case.
The Denominator Error
If I had divided the 31 new cases by all 4,000 patients, the result would be 7.8 per 1,000, an underestimate. Patients who already have diabetes cannot develop it again and do not belong in the at-risk population. This is the most common error in calculating incidence from clinic data.
Incidence Rate
Cumulative incidence assumes every patient was followed for the whole year. In reality, patients join and leave the clinic. Our record system shows that the 3,480 at-risk patients contributed 3,300 person-years of observation, since some transferred, moved or died and some new patients joined. The incidence rate is 31 divided by 3,300 person-years, or 9.4 per 1,000 person-years. This measure handles unequal follow-up more accurately (Noordzij et al., 2010).
National Comparison: Diagnosed Diabetes
Geiss et al. (2014) analyzed national survey data from 1980 to 2012 and found that the prevalence of diagnosed diabetes among adults aged 20 to 79 rose from 3.5 per 100 in 1990 to 8.3 per 100 in 2012, and incidence rose from 3.2 per 1,000 in 1990 to 8.8 in 2008 before falling to 7.1 in 2012. Incidence continued to rise among non-Hispanic Black and Hispanic adults and prevalence rose faster among adults with a high school education or less.
Interpreting Our Numbers
Our 13.0% prevalence of diagnosed diabetes is well above the national 8.3%. Our incidence of 9.4 per 1,000 person-years is also above the national 7.1 per 1,000. Our panel is older, poorer and has more Black adults than the national population, all groups with higher rates, so some difference is expected. Age standardization would make the comparison fairer; I plan to calculate age-specific rates next.
Undiagnosed Diabetes
Menke et al. (2015) used national examination data with laboratory testing and estimated total diabetes prevalence at 12% to 14% of U.S. adults in 2011 to 2012, depending on the criteria, with a substantial share undiagnosed, particularly among Asian and Hispanic adults. Our clinic's numbers include only diagnosed cases. If a similar share of our patients has undiagnosed diabetes, our true prevalence is higher than 13%.
Screening Coverage Affects Our Rates
Our incidence depends partly on how often we screen. If A1c screening increased, we would detect more existing cases, and incidence would rise temporarily even if the true occurrence of disease did not change. This is a key limitation when using clinic data to judge trends.
Relationship Between Prevalence and Incidence
In a stable population, prevalence roughly equals incidence multiplied by average disease duration. Because diabetes lasts for decades and patients live longer with better treatment, prevalence can rise even when incidence is flat, which is what Geiss et al. (2014) observed nationally after 2008.
Uses for Our Clinic
Prevalence supports planning: 520 patients means about 520 annual eye examinations, 2,080 A1c tests if quarterly, and staffing for education. Incidence supports prevention: 31 new cases a year among 3,480 at risk suggests a target population for a diabetes prevention program, especially patients with prediabetes.
Period Prevalence Versus Point Prevalence
Point prevalence counts cases on a single day. Period prevalence counts everyone who had the condition at any time during a period, including new cases and patients who left. Over the full year, 551 patients had diabetes at some point, the 520 existing cases plus the 31 new ones, among 4,120 adults seen, a period prevalence of 13.4%. Period prevalence is slightly higher because it adds new cases and a larger, changing population. For planning annual services, it may be the more useful figure.
Prediabetes as a Hidden Denominator
The at-risk population is not uniform. Patients with prediabetes, an A1c between 5.7% and 6.4%, develop diabetes at much higher rates than those with normal values. Calculating incidence separately for this group would show where prevention would do the most good and give our director a more precise target.
Limitations
Our data come from diagnosis codes, which may miss some patients and misclassify others. Our population changes as patients join and leave. Our numbers are small, so year-to-year variation is expected. I will report rates with confidence intervals in future analyses.
Reporting Uncertainty
With 31 new cases, a 95% confidence interval for the incidence rate runs roughly from 6.4 to 13.4 per 1,000 person-years. The national figure of 7.1 falls inside that range, so our higher incidence may partly reflect chance.
Next Steps
I will calculate age-specific and race-specific rates, estimate our prediabetes prevalence from A1c values in the record and repeat the incidence calculation for the past three years to see whether our trend matches national data.
Conclusion
Our clinic's diabetes prevalence is 13.0%, its cumulative incidence is 8.9 per 1,000 and its incidence rate is 9.4 per 1,000 person-years, all above national figures. Each measure answers a different question, and each depends on the right denominator. National data suggest that undiagnosed cases would raise our true burden further, and our screening practices will shape the incidence we observe.
References
Geiss, L. S., Wang, J., Cheng, Y. J., Thompson, T. J., Barker, L., Li, Y., Albright, A. L., & Gregg, E. W. (2014). Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA, 312(12), 1218-1226. https://doi.org/10.1001/jama.2014.11494
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015). Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA, 314(10), 1021-1029. https://doi.org/10.1001/jama.2015.10029
Noordzij, M., Dekker, F. W., Zoccali, C., & Jager, K. J. (2010). Measures of disease frequency: Prevalence and incidence. Nephron Clinical Practice, 115(1), c17-c20. https://doi.org/10.1159/000286345
How this DNP 701 Week 1 example is structured
The DNP/701 Week 1 work usually introduces measures of disease frequency. This paper defines each measure, calculates it from practice data with the working shown, interprets it against national benchmarks and names the limits of the clinic's numbers. Students search this week as DNP 701 Week 1, DNP701 Wk 1 or DNP/701 Wk 1; all three are the same assignment.
DNP/701 Week 1 questions, answered
What does DNP/701 Week 1 usually ask for?
Many sections ask students to define and calculate measures of disease frequency, such as prevalence and incidence, and to interpret them for a population in their practice.
What is the difference between prevalence and incidence?
Prevalence is the proportion of a population that has a condition at a point or period in time; incidence measures new cases arising in a population at risk over a period, either as a proportion (cumulative incidence) or per person-time (incidence rate).
Why does the denominator matter?
Incidence must be calculated only among people at risk, excluding those who already have the condition; including them makes the rate too low and hides the true pace of new disease.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.